Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
99% High Purity Product Discreet and Secure Shipping Certified Products For research purposes only
doi: 10.3390/foods6100092 PMCID: PMC5664031 Curcumin: A Review of Its Effects on Human Health Susan J
Vitamin B12 deficiency and cognitive impairment: A comprehensive review
Molecular Characteristics Molecular Type: Synthetic pentadecapeptide research compound Structure: Linear peptide chain (15 amino acids) Stability: High when stored under recommended laboratory conditions Molecular Weight: Sequence-dependent Stability Characteristics and Storage Guidance Supplied as a lyophilized powder for long-term molecular stability Recommended storage: 20C for extended preservation Sensitive to humidity and prolonged light exposure Predictable degradation above room temperature Reconstituted solutions remain stable for approximately 2448 hours under refrigeration Solubility and Experimental Handling Bacteriostatic water Sterile saline solutions Acidic laboratory buffers Compatible analytical-grade organic solvents Technical Overview product Name BPC-157 15mg cas 137525-51-0 purity 99% (HPLC verified) unit Size 15 mg vial form Lyophilized research powder synthesis Solid-Phase Peptide Synthesis (SPPS) analytical HPLC, Mass Spectrometry, UV Spectrophotometry molecular Structure Linear synthetic peptide chain stability High under appropriate laboratory storage Quality Assurance and Analytical Control High-Performance Liquid Chromatography (HPLC) purity verification Mass Spectrometry (MS) molecular identity and sequence confirmation UV spectrophotometric concentration assessment Batch consistency and reproducibility checks Endotoxin and microbial screening for research suitability Regulatory Position and Intended Use BPC-157 15mg is supplied strictly for laboratory research and scientific investigation
Research use only BPC-157 + TB-500 blend research peptide BPC-157 + TB-500 is a synthetic research peptide blend containing BPC-157 and TB-500
By the second to fourth week, most patients begin to experience more noticeable improvements
